DAEWON PHARMACEUTICAL CO.,LTD
Develops and manufactures prescription drugs and finished pharmaceutical products.
003220 | KO
Overview
Corporate Details
- ISIN(s):
- KR7003220001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 성동구 천호대로 386 대원제약, 서울특별시
- Website:
- https://www.daewonpharm.com/eng
- Sector:
- Manufacturing
Description
Daewon Pharmaceutical Co., Ltd., established in 1958, is a pharmaceutical company focused on improving human health. The company specializes in the development and manufacturing of prescription drugs and finished pharmaceutical products. Its portfolio includes a range of medications such as antipyretics, analgesics, and treatments for respiratory and cardiovascular conditions. Daewon Pharmaceutical maintains a strong commitment to research and development, with a strategic focus on New Chemical Entities (NCE) and Incrementally Modified Drugs (IMD) to provide advanced healthcare solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-16 00:00 |
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
|
Korean | 6.1 KB | ||
| 2025-12-16 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.0 KB | ||
| 2025-09-17 00:00 |
[기재정정]투자판단관련주요경영사항 (코대원플러스정 식품의약품안전처 국내 품목허가 신청)
|
Korean | 24.0 KB | ||
| 2025-09-09 00:00 |
자기주식처분결과보고서
|
Korean | 19.3 KB | ||
| 2025-09-09 00:00 |
유상증자또는주식관련사채등의발행결과(자율공시)
|
Korean | 6.0 KB | ||
| 2025-09-02 00:00 |
주요사항보고서(교환사채권발행결정)
|
Korean | 34.4 KB | ||
| 2025-09-02 00:00 |
주요사항보고서(자기주식처분결정)
|
Korean | 31.4 KB | ||
| 2025-08-29 00:00 |
공정거래자율준수프로그램운영현황(안내공시)
|
Korean | 16.5 KB | ||
| 2025-08-25 00:00 |
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
|
Korean | 13.7 KB | ||
| 2025-08-19 00:00 |
[기재정정]감자결정(종속회사의주요경영사항)
|
Korean | 20.0 KB | ||
| 2025-08-14 00:00 |
반기보고서 (2025.06)
|
Korean | 2.7 MB | ||
| 2025-08-12 00:00 |
감자결정(종속회사의주요경영사항)
|
Korean | 16.1 KB | ||
| 2025-06-02 00:00 |
기업지배구조보고서공시
|
Korean | 946.4 KB | ||
| 2025-05-30 00:00 |
투자판단관련주요경영사항 (코대원플러스정 식품의약품안전처 국내 품목허가 신청)
|
Korean | 10.9 KB | ||
| 2025-05-23 00:00 |
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
|
Korean | 13.2 KB |
Automate Your Workflow. Get a real-time feed of all DAEWON PHARMACEUTICAL CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DAEWON PHARMACEUTICAL CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DAEWON PHARMACEUTICAL CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
